Everything on Global Market Dynamics

US commercial markets drive 70 to 80 percent of global biopharma profits due to higher net pricing, while EU and China face structural reimbursement and regulatory constraints.

Impact: Requires asymmetric geographic allocation and hedging strategies to balance innovation incentives against policy volatility.

— from Leveraging Permanent Capital & AI in Biotech Investing · OHNE AKTIEN WIRD SCHWER - Tägliche Börsen-News· Jul 18, 2026